The median age at first cancer diagnosis was 40 years (range: 27–64 years) in 30 CRC patients carrying the POLE mutation and 32.5 years (range 23–57 years) in 13 CRC patients with POLD1 mutations [3]. This evidence concerns the gene POLE and cancer.